RAINBOW CHILDRENS MEDICARE
|
RAINBOW CHILDRENS MEDICARE Last 5 Year Financial Ratios History
[Consolidated]
| Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 20.77 | 14.70 | 9.10 | 12.68 | 13.12 |
| CEPS(Rs) | 29.82 | 23.60 | 12.53 | 13.84 | 10.52 |
| DPS(Rs) | 3.00 | 2.00 | - | - | 1.00 |
| Book NAV/Share(Rs) | 104.42 | 62.93 | 99.05 | 89.73 | 92.01 |
| Tax Rate(%) | 24.63 | 25.98 | 28.96 | 40.72 | 25.37 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 34.05 | 31.61 | 25.40 | 27.90 | 20.61 |
| EBIT Margin(%) | 28.99 | 25.01 | 15.70 | 19.69 | 15.35 |
| Pre Tax Margin(%) | 24.01 | 19.24 | 8.57 | 12.98 | 14.30 |
| PAT Margin (%) | 18.10 | 14.24 | 6.09 | 7.69 | 10.67 |
| Cash Profit Margin (%) | 25.79 | 22.79 | 17.37 | 17.34 | 17.47 |
| Performance Ratios | |||||
| ROA(%) | 14.00 | 11.74 | 3.64 | 6.68 | 11.51 |
| ROE(%) | 25.72 | 27.00 | 9.54 | 13.85 | 15.34 |
| ROCE(%) | 39.96 | 42.92 | 21.37 | 30.49 | 19.81 |
| Asset Turnover(x) | 0.77 | 0.82 | 0.60 | 0.87 | 1.08 |
| Sales/Fixed Asset(x) | 0.95 | 0.90 | 0.70 | 1.12 | 1.41 |
| Working Capital/Sales(x) | 3.46 | 5.90 | 8.66 | 9.90 | 10.91 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.06 | 1.11 | 1.42 | 0.89 | 0.71 |
| Receivable days | 15.36 | 15.81 | 24.69 | 18.40 | 14.78 |
| Inventory Days | 5.22 | 4.67 | 7.32 | 5.83 | 4.36 |
| Payable days | 171.64 | 110.68 | 197.76 | 161.38 | 134.76 |
| Valuation Parameters | |||||
| PER(x) | 35.16 | - | - | - | - |
| PCE(x) | 24.49 | - | - | - | - |
| Price/Book(x) | 6.99 | - | - | - | - |
| Yield(%) | 0.41 | - | - | - | - |
| EV/Net Sales(x) | 6.28 | -0.04 | 0.01 | 0.02 | 0.06 |
| EV/Core EBITDA(x) | 17.11 | -0.12 | 0.03 | 0.07 | 0.25 |
| EV/EBIT(x) | 21.66 | -0.17 | 0.06 | 0.11 | 0.37 |
| EV/CE(x) | 4.21 | -0.03 | 0.01 | 0.01 | 0.05 |
| M Cap / Sales | 6.32 | - | - | - | - |
| Growth Ratio | |||||
| Net Sales Growth(%) | 20.52 | 49.80 | -9.64 | 32.54 | 35.08 |
| Core EBITDA Growth(%) | 31.72 | 86.30 | -16.88 | 75.52 | 51.94 |
| EBIT Growth(%) | 39.69 | 138.58 | -27.93 | 69.99 | 63.19 |
| PAT Growth(%) | 53.15 | 250.47 | -28.50 | -4.47 | 59.67 |
| EPS Growth(%) | 41.30 | 61.48 | -28.19 | -3.41 | 61.61 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | 0.07 | 0.10 | 0.14 | 0.12 |
| Current Ratio(x) | 3.35 | 2.32 | 1.61 | 1.42 | 1.58 |
| Quick Ratio(x) | 3.22 | 2.20 | 1.53 | 1.33 | 1.50 |
| Interest Cover(x) | 5.83 | 4.34 | 2.20 | 2.93 | 14.64 |
| Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of RAINBOW CHILDRENS MEDICARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| RAINBOW CHILDRENS MEDICARE | ₹13,758.8 Cr | 6.7% | -2% | 68.5% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹90,042.3 Cr | 3.4% | -6.6% | 49% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹79,011.6 Cr | 5.7% | -8.7% | 59.1% | Stock Analytics | |
| GLOBAL HEALTH | ₹38,724.1 Cr | 6.7% | -13.1% | 164.4% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹33,995.8 Cr | 2.6% | -6.4% | 59.4% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹25,809.8 Cr | 2% | -9.6% | 59.5% | Stock Analytics | |
RAINBOW CHILDRENS MEDICARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| RAINBOW CHILDRENS MEDICARE | 6.7% |
-2% |
68.5% |
| SENSEX | 1.3% |
2.6% |
24% |
You may also like the below Video Courses
